Synapse - Works

Results (4073)

Phase II trial of bortezomib in combination with fractionated cyclophosphamide and rituximab (BCR) for relapsed/refractory mantle cell lymphoma (MCL)

Meeting Abstract

Romaguera, J. E.; Fanale, M. A.; Samaniego, F.; Fayad, L. E.; Hagemeister, F. B.; McLaughlin, P.; Rodriguez, M. A.; Weaver, P.; Hartig, K.; Badillo, M.; more...
Blood (2013)

Fulltext@MSK | Save

Kinase activity of Pak2, an effector of Rac/CDC42 and its interaction with β-PIX is required for murine hematopoietic stem cell shape, F-actin formation, directional migration in vitro and for HSPC homing to bone marrow in vivo

Meeting Abstract

Reddy, P. N. G.; Wood, J.; Harris, C. E.; Xu, K.; McGuinness, M.; Radu, M.; Kosoff, R.; Chernoff, J.; Williams, D. A.
Blood (2013)

Fulltext@MSK | Save

The hematopoietic cell transplant-co-morbidity index (HCT-CI) predicts outcomes after T cell depleted (TCD) allogeneic HCT for AML and MDS

Meeting Abstract

Ratan, R.; Ceberio, I.; Hilden, P.; Devlin, S. M.; Malloy, M. A.; Barker, J. N.; Castro-Malaspina, H.; Jakubowski, A. A.; Koehne, G.; Papadopoulos, E. B.; more...
Blood (2013)

Fulltext@MSK | Save

High day 28 ST2 biomarker levels predict severe day 100 acute graft-versus-host disease and day 180 transplant-related mortality after double-unit cord blood transplantation

Meeting Abstract

Ponce, D. M.; Hilden, P.; Mumaw, C.; Devlin, S.; Lubin, M. N.; Evans, K. L.; Prockop, S.; Scaradavou, A.; Kernan, N. A.; Giralt, S. A.; more...
Blood (2013)

Fulltext@MSK | Save

Analysis of 402 cord blood units to assess factors influencing infused viable CD34+ cell dose: The critical determinant of engraftment

Meeting Abstract

Purtill, D.; Smith, K. M.; Tonon, J.; Evans, K. L.; Lubin, M. N.; Byam, C.; Ponce, D. M.; Scaradavou, A.; Stevens, C. E.; Barker, J. N.
Blood (2013)

Fulltext@MSK | Save

Azacitidine with or without entinostat for the treatment of therapy-related myeloid neoplasm: Further results of the E1905 North American Leukemia Intergroup Study

Meeting Abstract

Prebet, T.; Sun, Z.; Ketterling, R.; Greenberg, P. L.; Zeidan, A. M.; Litzow, M. R.; Gabrilove, J. L.; Erba, H. P.; Paietta, E.; Czader, M.; more...
Blood (2013)

Fulltext@MSK | Save

A phase I/II open-label multicenter study of the cyclin kinase inhibitor AT7519M alone and in combination with bortezomib in patients with previously treated multiple myeloma

Meeting Abstract

Raje, N.; Hari, P. N.; Landau, H.; Richardson, P. G.; Rosenblatt, J.; Couture, N.; Lyons, J. F.; Langford, G.; Yule, M.
Blood (2013)

Fulltext@MSK | Save

Integrated genetic profiling of JAK2 wildtype chronic-phase myeloproliferative neoplasms

Meeting Abstract

Rampal, R. K.; Devlin, S. M.; Patel, J. P.; Knapp, K. M.; Patel, M.; Greenbowe, J. R.; Young, L. E.; He, J.; Wang, K.; Nahas, M. K.; more...
Blood (2013)

Fulltext@MSK | Save

Adoptive treatment of EBV-associated leiomyosarcoma in immunodeficient patients with EBV specific cytotoxic T cells

Meeting Abstract

Prockop, S. E.; Doubrovina, E.; Boulad, F.; Kernan, N. A.; Kobos, R.; Scaradavou, A.; Abramson, S. J.; Laquaglia, M.; Price, A.; O'Reilly, R. J.
Blood (2013)

Fulltext@MSK | Save

Adoptive transfer of WT-1 specific HLA class 2 restricted donor-derived T-cells induces sustained remission of AML relapse post transplant presenting as leukemia cutis

Meeting Abstract

Prockop, S. E.; Doubrovina, E.; Adams, R.; Boulad, F.; Kernan, N. A.; O'Reilly, R. J.
Blood (2013)

Fulltext@MSK | Save